Medication Guide App

Romiplostim

In the US, Romiplostim (romiplostim systemic) is a member of the drug class platelet-stimulating agents and is used to treat Idiopathic Thrombocytopenic Purpura.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B02BX04

CAS registry number (Chemical Abstracts Service)

0267639-76-9

Chemical Formula

C2634-H4086-N722-O790-S18

Molecular Weight

59085

Therapeutic Categories

Hematopoietic growth factor: Stimulation of thrombopoiesis

Hemostatic agent: Treatment of thrombocytopenia

Thrombopoietin receptor agonist

Chemical Names

L-methionyl [human immunglobulin heavy constant gamma 1-(227 C-terminal residues)-peptide (Fc fragment)] fusion protein with 41 amino acids peptide, (7-7':10,10')-bisdisulfide dimer (WHO)

Methionyl, 227 amino acid C-terminal Immunoglobulin G1 (human Fc fragment) fusion protein with 41 amino acid peptide, dimer (USAN)

Foreign Names

  • Romiplostimum (Latin)
  • Romiplostim (German)
  • Romiplostim (French)
  • Romiplostim (Spanish)

Generic Names

  • Romiplostim (OS: USAN, BAN)
  • AMG 531 (IS: Amgen)

Brand Names

  • Nplate
    Amgen, Austria; Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Iceland; Amgen, Latvia; Amgen, Netherlands; Amgen, Norway; Amgen, Romania; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Dompè, Italy; Amgen Europe, Denmark; Amgen Europe, Lithuania; Amgen Ltd., Ireland; Amgen Switzerland, Switzerland

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)